|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV052596745 |
003 |
DE-627 |
005 |
20230624184845.0 |
007 |
cr uuu---uuuuu |
008 |
210910s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.pcd.2020.06.004
|2 doi
|
028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001249.pica
|
035 |
|
|
|a (DE-627)ELV052596745
|
035 |
|
|
|a (ELSEVIER)S1751-9918(20)30216-3
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
4 |
|a 630
|q VZ
|
082 |
0 |
4 |
|a 640
|q VZ
|
082 |
0 |
4 |
|a 590
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 600
|q VZ
|
084 |
|
|
|a 50.70
|2 bkl
|
100 |
1 |
|
|a Ruiz-Quintero, Manuel
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort
|
264 |
|
1 |
|c 2021
|
300 |
|
|
|a 7
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a • A eGFR<90mL/min/1.73m2 was associated with increased mortality risk (p <0.001). • A eGFR<90mL/min/1.73m2 was associated with increased hospitalizations (p <0.001). • Mortality estimated PAR associated with eGFR levels<60 was significant in DM. • Mortality estimated PAR associated with eGFR levels<60 was significant in CVD.
|
650 |
|
7 |
|a Hypertension
|2 Elsevier
|
650 |
|
7 |
|a Attributable risk
|2 Elsevier
|
650 |
|
7 |
|a Diabetes mellitus
|2 Elsevier
|
650 |
|
7 |
|a Mortality
|2 Elsevier
|
650 |
|
7 |
|a Kidney dysfunction
|2 Elsevier
|
650 |
|
7 |
|a Cardiovascular diseases
|2 Elsevier
|
700 |
1 |
|
|a Redón, Josep
|4 oth
|
700 |
1 |
|
|a Téllez-Plaza, María
|4 oth
|
700 |
1 |
|
|a Cebrián-Cuenca, Ana M.
|4 oth
|
700 |
1 |
|
|a Navarro-Pérez, Jorge
|4 oth
|
700 |
1 |
|
|a Menéndez, Edelmiro
|4 oth
|
700 |
1 |
|
|a Perez-Navarro, Ana
|4 oth
|
700 |
1 |
|
|a Fernández-Giménez, Antonio
|4 oth
|
700 |
1 |
|
|a López-Pineda, Adriana
|4 oth
|
700 |
1 |
|
|a Quesada, José A.
|4 oth
|
700 |
1 |
|
|a Pallares-Carratalá, Vicente
|4 oth
|
700 |
1 |
|
|a Gil-Guillen, Vicente F.
|4 oth
|
700 |
1 |
|
|a Martin-Moreno, José M.
|4 oth
|
700 |
1 |
|
|a Bleda-Cano, Jesús
|4 oth
|
700 |
1 |
|
|a Carrascosa, Sara
|4 oth
|
700 |
1 |
|
|a Carratalá-Munuera, Concepción
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
773 |
1 |
8 |
|g volume:15
|g year:2021
|g number:1
|g pages:88-94
|g extent:7
|
856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2020.06.004
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 15
|j 2021
|e 1
|h 88-94
|g 7
|